Pharmaceuticals, Biotechnology and Life Sciences
Event Scheduled for 8:00 a.m. ET Thursday, January 7, 2021 LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host…
Event Scheduled for 8:00 a.m. ET Thursday, January 7, 2021 LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host…
LONDON–(BUSINESS WIRE)–#GlobalCellViabilityAssaysMarket–The cell viability assays market is poised to grow by USD 1.40 billion during 2020-2024, progressing at a CAGR…
LONDON–(BUSINESS WIRE)–#GlobalCellViabilityAssaysMarket–The cell viability assays market is poised to grow by USD 1.40 billion during 2020-2024, progressing at a CAGR…
LONDON–(BUSINESS WIRE)–#GlobalCellViabilityAssaysMarket–The cell viability assays market is poised to grow by USD 1.40 billion during 2020-2024, progressing at a CAGR…
LONDON–(BUSINESS WIRE)–#GlobalCellViabilityAssaysMarket–The cell viability assays market is poised to grow by USD 1.40 billion during 2020-2024, progressing at a CAGR…
LONDON–(BUSINESS WIRE)–#GlobalCellViabilityAssaysMarket–The cell viability assays market is poised to grow by USD 1.40 billion during 2020-2024, progressing at a CAGR…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that Andrew…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that Andrew…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that Andrew…